Introduction
The overall purpose of these guidelines is to help physicians manage adults with tuberculosis (TB)/human immunodeficiency virus (HIV) co-infection. Recommendations for the treatment of TB in adults living with HIV are similar to those in HIV-negative adults. Of note, the term ‘HIV’ refers to HIV-1 throughout these guidelines.
The 2018 BHIVA guidelines for the management of tuberculosis in adults living with HIV were updated in 2021, 2022 and 2023. All changes are highlighted.
Downloads
Additional information
Literature search strategies
Consultation comments
Comments received by the BHIVA Secretariat during the public consultation process
Declaration of interests
Declaration of interests from writing group members
Non-technical summary
Please note: The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with your healthcare professionals.
Writing group
Anton Pozniak (Chair), Margherita Bracchi, Clare van Halsema, Funmi Awosusi, Alison Barbour, Steve Bradley, Katherine Coyne, Ben Cromarty, Esther Dixon-Williams, Andrew Freedman, Pauline Jelliman, Saye Khoo, Clifford Leen, Marc Lipman, Sebastian Lucas, Rob Miller, Nicoletta Policek, Kay Seden
Peer review
The guidelines were peer reviewed by Dr Jose Miro, University of Barcelona, Spain, and Professor Graeme Meintjes, University of Cape Town (UCT), South Africa.
Guideline updates and date of next review
We aim to revise these guidelines in 2023. In the meantime, the writing group will confer at least annually to consider new information from high-quality studies and will issue revisions or updates should clinically important and relevant data become available.
Reference
Bracchi M, van Halsema C, Post F et al. British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2019. HIV Med 2019; 20 Suppl 6: s2-s83.